Probably the best lecture I've ever sat through. So, well worth watching this lecture:
I in particular loved his opening address, giving credit to so many and the caution against selecting studies that reenforce your starting biases.
Touches on my usual key points too
- compliance failures
- lack of interest in studying a drug which is not going to make Pharma a lot of money
